There is great medical need to develop novel therapies for treatment of human hepatitis C virus (HCV). By gene expression analysis of three HCV-subgenomic RNA replicon cell lines, we identified cellular proteins whose expression is affected by the presence of HCV and therefore may serve as drug targets. Data from cDNA array filter hybridization, as well as from Northern and Western blotting, revealed that the gastrointestinal-glutathione peroxidase (GI-GPx) was drastically down-regulated (up to 20-fold) in all replicon cell lines tested. Concomitantly, total cellular glutathione peroxidase activity was drastically reduced, which rendered these human liver cells more susceptible toward oxidative stress. Interferon ␣ caused down-regulation of the HCVreplicon followed by recovery of GI-GPx expression to nearly normal levels. Furthermore, expression of GIGPx in replicon cells by gene transduction caused downregulation of HCV RNA in a dose-dependent manner. Moreover, activating the endogenous gene coding for GI-GPx by all-trans-retinoic acid (RA) was sufficient to cause down-regulation of the HCV replicon. A small interfering RNA duplex abrogated GI-GPx up-regulation by RA and concomitantly suppression of HCV. The RA effect was dependent on the presence of sodium selenite, was reversible, and was independent of RNA-activated protein kinase. Taken together, these results show that HCV inhibits the expression of GI-GPx in replicon cells to promote its intracellular propagation. Modulation of GI-GPx activity may open new avenues of treatment for HCV patients.
The hepatitis C virus (HCV)1 infects ϳ2% of the population worldwide (1), and more than 80% of these patients become chronically infected causing recurring hepatitis, liver cirrhosis, and cancer. HCV-related end-stage liver disease is now the leading reason for liver transplantation. Interferon (IFN) monotherapy is effective in only 10% of HCV patients (2-4), and the combination of pegylated interferon and ribavirin can eradicate the virus in about 50% of patients (reviewed in Ref.